Status: current, Not sufficiently defined by necessary conditions definition status. Date: 03-Aug 2022. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2370291000001110 | Bulevirtide acetate | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2370301000001114 | Bulevirtide acetate (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Bulevirtide acetate | Is a | Substance with antiviral mechanism of action | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Bulevirtide 2mg powder for solution for injection vials | Has specific active ingredient | True | Bulevirtide acetate | Inferred relationship | Existential restriction modifier | |
| Hepcludex 2mg powder for solution for injection vials (Gilead Sciences Ltd) | Has specific active ingredient | True | Bulevirtide acetate | Inferred relationship | Existential restriction modifier | |
| Hepcludex 2mg powder for solution for injection vials (Gilead Sciences Ltd) 30 vial | Has specific active ingredient | True | Bulevirtide acetate | Inferred relationship | Existential restriction modifier | |
| Bulevirtide 2mg powder for solution for injection vials 30 vial | Has specific active ingredient | True | Bulevirtide acetate | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR